Natco Pharma has informed that it enclosed the Press Release under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 regarding the completion of acquisition of additional 13.25% stake in Adcock Ingram Holdings Proprietary.
The above information is a part of company’s filings submitted to BSE.